Results of stability studies with doping agents in urine

Journal of Analytical Toxicology

Volumn 31, Issue 9, 2007, Pages 543-548

  Van Eenoo, Peter ^a   Lootens, L ^a   Spaerkeer, A ^a   Van Thuyne, W ^a   Deventer, K ^a   Delbeke, F T ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

19 NORANDROSTERONE GLUCURONIDE; ACETAZOLAMIDE; ALTIZIDE; AMILORIDE; ANDROSTERONE DERIVATIVE; BEMITIZIDE; BENDROFLUMETHIAZIDE; BUMETANIDE; CHLORTALIDONE; CLOPAMIDE; CYCLOPENTHIAZIDE; DICLOFENAMIDE; DIURETIC AGENT; EPHEDRINE; EPITIZIDE; ETACRYNIC ACID; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROFLUMETHIAZIDE; INDAPAMIDE; MEBUTHIAZIDE; METHYLEPHEDRINE; NORPSEUDOEPHEDRINE; PIRETANIDE; POLYTHIAZIDE; PROBENECID; TORASEMIDE; TRIAMTERENE; TRICHLORMETHIAZIDE; UNCLASSIFIED DRUG; XIPAMIDE;

ARTICLE; CONTROLLED STUDY; DOPING; DRUG STABILITY; HUMAN; STATISTICAL SIGNIFICANCE; URINALYSIS;

EID: 37349033875     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.9.543     Document Type: Article

References (34)

1. World Anti-Doping Agency. The World Anti-Doping Code, 2003. http://www.wada-ama.org/
2. World Anti-Doping Agency. International Standard. The 2007 Prohibited List.
3. World Anti-Doping Agency. International Standard for Testing, version 3.0, June 2003.
4. World Anti-Doping Agency. International Standard for Laboratories version 4.0, August 2004.
5. R. Ventura, C. Jimenez , N. Closas , J. Segura, and R. De la Torre. Stability studies of selected doping agents in urine: caffeine. J. Chromatogr. B 795: 167-177 (2003).
6. G. Forsdahl and G. Gmeiner. Quantification and stability of salbutamol in human urine. J. Sep. Sci. 27: 110-114 (2004).
7. 9-tetrahydrocannabinol-9carboxylic acid in authentic urine samples J. Anal. Toxicol. 28: 35-40 (2004).
8. 9-tetrahydrocannabinol-9-carboxylic acid J. Anal. Toxicol. 29: 627-631 (2005).
9. B.L. Chang, M.K. Huang, and Y.Y. Tsai. Total morphine stability in urine specimens stored under various conditions. J. Anal. Toxicol. 24: 442-447 (2000).
10. D.L. Lin, H. Liu, and C.Y. Chen. Storage-temperature effect on the stability of morphine and codeine in urine. J. Anal. Toxicol. 19: 275-280 (1995).
11. M.J. Hippenstiel and B. Gerson. Optimization of storageconditions for cocaine and benzoylecgonine in urine - a review. J. Anal. Toxicol. 18: 104-109 (1994).
12. V. Belalcazar, J.A. Pascual, S. Abanades, M. Farre, and R. Torre. Stability of EPO in urine stabilized by sodium azide. In Recent Advances in Doping Analysis (13), W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck , Eds. Sportverlag Strauss, Cologne, Germany, 2005, pp. 427-431.
13. V. Belalcazar, R. Gutiérrez Gallego, E. Llop, J. Segura, and J.A. Pascual. Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine. Electrophoresis 27: 4387-4395 (2006).
14. K.M. Clauwaert, J.F. Van Boxlaer, and A.P. De Leenheer. Stability study of the designer drugs "MDA, MDMA and MDEX" in water, serum, whole blood, and urine under various storage temperatures. Forensic Sci. Int. 12: 36-42 (2001).
15. C. Jiménez, R. de la Torre, M. Ventura, J. Segura, and R. Ventura. Stability studies of amphetamine and ephedrine derivatives in urine. J. Chromatogr. B 843: 84-93 (2006).
16. P.J. van der Merwe and E. Grobbelaar. Stability of 19-norandrosterone and 19-noretiocholanolone glucuronide in urine under various storage conditions. S.A. Sports Med. 15: 14-17 (2003).
17. C. Jimenez, R. de la Torre, J. Segura, and R. Ventura. Stability studies of testosterone and epitestosterone glucuronides in urine. Rapid Commun. Mass Spectrom. 20: 858-864 (2006).
18. P.J. van der Merwe and J.W. Pieterse. Stability of zeranol, nandrolone and trenbolone in bovine urine. Analyst 119: 2651-2653 (1994).
19. S. Sterk, F. van Tricht, B. Le, L. van Ginkel, and R. Stephany. Production and stability testing of incurred reference materials for the anabolic steroid trenbolone in bovine urine. Analyst 123: 2563-2566 (1998).
20. P. Gonzalez-Gisos, C. Fente-Sampayo, C. Franco-Abuin, A. Cpedea-Saez, and B.I. Vazquez-Belda. Effects of frozen storage on the recovery of clenbuterol from urine samples for official control. Food Addit. Contam. 19: 1010-1014 (2002).
21. C. Saudan, J.M. Entenza, N. Baume, P. Mangin, and M. Saugy. Short-term stability of testosterone and epitestosterone conjugates in urine samples: Quantification by liquid chromatographylinear ion trap mass spectrometry. J. Chromatogr. B 844: 168-174 (2006).
22. R. de la Torre, X. de la Torre, C. Alia, J. Segura, T. Baro, and J.M. Torres-Rodriguez. Changes in androgenic steroid profile due to urine contamination by microorganisms: A prospective study in the context of doping control. Anal. Biochem 289: 116-123 (2001).
23. J. W. Honour. Testing for drug abuse. Lancet 348: 41-43 (1996).
24. A.G. Ghanekar, V. Das Gupta, and C.W. Gibbs. Stability of furosemide in aqueous systems. J. Pharm. Sci. 67: 808-811 (1978).
25. D. Thieme, J. Grosse, R. Lang, R.K. Mueller, and A. Wahl. Screening, confirmation and quantitation of diuretics in urine for doping control analysis by high-performance liquid chromatography-atmospheric pressure ionisation tandem mass spectrometry. J. Chromatogr. B 757: 49-57 (2001).
26. M.J. Ruiz Angel, M.T. Gil Agusti, J.S. Esteve Romero, and S. Carda Broch. Photodegradation and photostability studies of bendroflumethiazide (BFMT) in pharmaceutical formulations and urine samples by micellar liquid chromatography. LCGC Europe 18: 32-40 (2004).
27. P. Van Eenoo, F.T. Delbeke, K. Roels, and P. De Backer. Simultaneous quantitation of ephedrines in urine by gas chromatography-nitrogen-phosphorus detection for doping control purposes. J. Chromatogr. B 760: 255-261 (2001).
28. K. Deventer, P. Van Eenoo, and F.T. Delbeke. Simultaneous determination of beta-blocking agents and diuretics in doping analysis by liquid chromatography mass spectrometry with scan-to-scan polarity switching. Rapid Commun. Mass Spectrom. 19: 90-98 (2005).
29. P. Van Eenoo, A. Spaerkeer, and F.T. Delbeke. Stability studies of selected doping substances in methanolic solution. In Recent Advances in Doping Analysis (12), W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck , Eds. Sportverlag Strauss, Cologne, Germany, 2004, pp. 189-194.
30. ISO/IEC 17025:1999. General Requirements for the competence of calibration and testing laboratories. ISO, Geneva (1999).
31. P. Van Eenoo and F.T. Delbeke. Reply to "Measurement uncertainty and doping control in sport" by A. van der Veen, Accred. Qual. Assur. 8: 334-339 (2003).
32. Accred. Qual. Assur. 8: 477-479 (2003).
33. Eurachem/Citac Guide, quantifying uncertainty in analytical measurement, 2nd ed., 1-120.
34. International Laboratory Accreditation Cooperation (ILAC). ILAC G17:2002 Introducing the Concept of Uncertainty of Measurement in Testing in Association with the Application of the Standard ISO/IEC 17025. http://www.ilac.org/